NEPHROS INC POS AM, filed Mar 23, 2018: IDEA: XBRL DOCUMENT
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Income Tax Disclosure [Abstract] | ||
| U.S. federal statutory rate | 35.00% | 35.00% |
| State taxes | (21.84%) | (5.21%) |
| Sale of NJ NOLS and credits | (68.91%) | 0.00% |
| Change in federal statutory rate | (441.07%) | 0.00% |
| Stock based compensation | (5.48%) | 0.00% |
| Other permanent difference due to sale of NJ NOLs and credits | (24.12%) | 0.00% |
| State research and development credits | 2.24% | 1.87% |
| Other | (12.46%) | 0.97% |
| Valuation allowance | 467.73% | (32.63%) |
| Effective tax rate | (68.91%) | 0.00% |